The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03386877
Previous Study | Return to List | Next Study

Periodontal Regeneration Using Dental Pulp Stem Cells (DPSCs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03386877
Recruitment Status : Completed
First Posted : December 29, 2017
Last Update Posted : December 29, 2017
Sponsor:
Information provided by (Responsible Party):
Francesco Ferrarotti, University of Turin, Italy

Brief Summary:
The goal of this study is to evaluate if dental pulp stem cells (DPSCs) delivered into intrabony defects in a collagen scaffold would enhance the clinical and radiographic parameters of periodontal regeneration.

Condition or disease Intervention/treatment Phase
Periodontal Diseases Procedure: periodontal regeneration Not Applicable

Detailed Description:
In this randomized controlled trial, 29 chronic periodontitis patients presenting one deep intrabony defect and requiring extraction of one vital tooth were consecutively enrolled. Defects were randomly assigned to test or control treatments which both consisted of the use of minimally invasive surgical technique. The dental pulp of the extracted tooth was mechanically dissociated to obtain micro-grafts rich in autologous DPSCs. Test sites (n=15) were filled with micro-grafts seeded onto collagen sponge, whereas control sites (n=14) with collagen sponge alone. Clinical and radiographic parameters were recorded at baseline, 6 and 12 months postoperatively.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 29 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Human Intrabony Defect Regeneration With Micro-grafts Containing Dental Pulp Stem Cells: a Randomized Controlled Clinical Trial.
Actual Study Start Date : January 25, 2016
Actual Primary Completion Date : April 28, 2017
Actual Study Completion Date : April 28, 2017

Arm Intervention/treatment
Experimental: Dental pulp stem cells
Test sites (n=15) Periodontal regeneration using micro-grafts of Dental pulp stem cells seeded onto collagen sponge
Procedure: periodontal regeneration
Defects were accessed with the MIST In the test group the obtained micro-grafts enriched in DPSCs were endorsed onto a collagen sponge scaffold (Condress®, Istituto Gentili, Milano, Italy) to form a bio-complex. In the control group the collagen sponge was only hydrated using physiologic sterile solution. The collagen sponge with or without cells was provided to the masked surgeon who filled the intrabony defect. The flaps were repositioned and tension-free primary flap closure was obtained using horizontal internal mattress and interrupted sutures

Active Comparator: coagulum
control sites (n=14) Periodontal regeneration using coagulum and collagen sponge alone
Procedure: periodontal regeneration
Defects were accessed with the MIST In the test group the obtained micro-grafts enriched in DPSCs were endorsed onto a collagen sponge scaffold (Condress®, Istituto Gentili, Milano, Italy) to form a bio-complex. In the control group the collagen sponge was only hydrated using physiologic sterile solution. The collagen sponge with or without cells was provided to the masked surgeon who filled the intrabony defect. The flaps were repositioned and tension-free primary flap closure was obtained using horizontal internal mattress and interrupted sutures




Primary Outcome Measures :
  1. Radiographic bone fill [ Time Frame: baseline and 12 months ]
    Periapical standardized radiographs were taken by a clinician masked to the clinical measurements using the paralleling technique and individually customized bite-blocks (RINN XCP Film Holding Instruments, Dentsply, York, USA)


Secondary Outcome Measures :
  1. Probing depth reduction [ Time Frame: baseline, 6 and 12 months ]
    Probing depth is assessed on the experimental teeth using periodontal probe (PCP 15/11.5, Hu-Friedy, Chicago, IL, USA)

  2. Clinical attachment gain [ Time Frame: baseline, 6 and 12 months ]
    Clinical attachment level is assessed on the experimental teeth using periodontal probe (PCP 15/11.5, Hu-Friedy, Chicago, IL, USA)

  3. Recession reduction [ Time Frame: baseline, 6 and 12 months ]
    Recession depth is assessed on the experimental teeth using periodontal probe (PCP 15/11.5, Hu-Friedy, Chicago, IL, USA)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • diagnosis of advanced chronic periodontitis
  • FMPS<20%
  • FMBS<20%
  • infrabony defect >2mm
  • Probing depth >5mm
  • presence of 1 vital and intact tooth requiring an extraction as autologous source of DPSCs

Exclusion Criteria:

  • smoking
  • controindicazion for periodontal surgery
  • systemic diseases affecting periodontal healing
  • pregnancy an lactation
  • fixed orthodontic appliance
  • history of periodontal surgery at the experimental teeth
  • prostethic restorations at the experimental teeth
  • furcation defects

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03386877


Locations
Layout table for location information
Italy
CIR dental school
Torino, Piedmont, Italy, 10126
CIR Dental school Turin University
Turin, Piedmont, Italy, 10126
Sponsors and Collaborators
University of Turin, Italy
Investigators
Layout table for investigator information
Principal Investigator: Mario Aimetti Turin University
Layout table for additonal information
Responsible Party: Francesco Ferrarotti, Adjunct Professor, University of Turin, Italy
ClinicalTrials.gov Identifier: NCT03386877    
Other Study ID Numbers: UTurin stem cell RCT
First Posted: December 29, 2017    Key Record Dates
Last Update Posted: December 29, 2017
Last Verified: December 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases